GlassScriptPrepare for your visit
Siamac Esfandi
Neurology (Psychiatry & Neurology) · Lakewood, CO · NPI 1225271455
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$774.60
in general payments reported to CMS, 2019-2025 · $301 in 2025
The $301 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Who reported paying
General payments only, top 6 by amount.
- Novartis Pharmaceuticals Corporation $360.42
- Biogen, INC. $169.11
- Celgene Corporation $81.32
- Pfizer INC. $59.89
- Emd Serono, INC. $36.71
- Ucb, INC. $34.50
Drugs and devices associated with these payments
Kesimpta Zeposia Tysabri Vumerity Zavzpret Nurtec Odt Mavenclad Fintepla
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Siamac Esfandi listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/100490/siamac-esfandi